Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


House Demands More Info On FDA Overseas Operations

Executive Summary

GAO to report on foreign office closures and risk-based inspection policy amid concerns that unequal playing field remains.


Related Content

US FDA’s New Compliance Chief Donald Ashley Brings International Law Enforcement Experience
Improved FDA Forensics Uncover More Manufacturing Data Integrity Issues
FDA Posts OCI Agent In Singapore, But Other Foreign Offices Close
GDUFA II: Inspection Information Takes Center Stage
FDA Field Operations Would Endure Reductions Under Budget





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts